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This study aimed to investigate any inflammatory effect of nicotine on rat embryo by exposing their mothers to different dosages
of nicotine during pregnancy. During this experimental study, 32 pregnant healthy Wistar rats were divided into 4 equal groups,
including a control and 3 nicotine exposure groups. Injections were performed subcutaneously starting at the first day of pregnancy
until parturition. As the dosages of nicotine were increased, the weight gain by pregnant rats and themeanweight of their newborns
were significantly reduced. Mean ± SD of hs-CRP was significantly higher among groups exposed to various dosages of nicotine
(2, 4, and 6mg/kg) compared to the control group (𝑃 < 0.0001) and its increasing rate was also dose dependent. Mean ± SD
serum level of IL-6 and TNF-𝛼 among all groups exposed to nicotine, except for 2mg/kg nicotine injected group, was increased
significantly (𝑃 < 0.0001). Mean ± SD of serum level of TGF-𝛽 and nitrite oxide among exposure groups showed significant
differences compared to the control group only at the dosage of 6mg/kg (𝑃 < 0.0001). The current study showed that exposing
pregnant rats to nicotine causes a dose dependent increase in the rate of all the studied inflammatory serum markers among their
newborns.
1. Introduction
Smoking during pregnancy is one the most important
problems in public health globally that causes different
harmful outcomes such as intrauterine growth retardation,
cardiovascular diseases, and abortion in fetus accompanied
with some complications in mothers [1, 2]. The majority
of cardiovascular complications due to smoking during
pregnancy are attributed to nicotine and previous studies
have reported that smoking during pregnancy can cause an
alteration in vascular activity in adolescence period. It also
causes a reduction in cardiac ability for rehabilitation after
ischemia among rats [3, 4]. Nicotine passes from placenta
and enters in fetus circulation and causes an increase in
vascular resistance and vasopressin that result in umbilical
vasoconstriction [5, 6]. Prevalence of prenatal smoking is
estimated as 11–30% [7]. There are different studies in the
literature that report congenital deficiency and behavioral
disorders due to smoking during pregnancy such as hyper-
activity, conductive disorder, nicotine dependency, and drug
abuse [8–14]. Prenatal exposure to nicotine causes a reduction
in explanation of PKCE protein which is a notable factor
for adolescence cardiovascular disorders [15]. Some other
cardiovascular abnormalities such as variations of heart
beats, fetus hypoxia, reduction of antioxidant enzyme of
myocardium, and creation of lipid peroxidation have been
attributed to prenatal nicotine by different studies [16–18].
Due to lack of information about exposure to nicotine during
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Table 1: General characteristics of rats and their newborns in 4 different groups.
Variable (𝑛) Control (8) 2mg/kg/day (8) 4mg/kg/day (8) 6mg/kg/day (8)
Pregnancy duration (hrs) 541.8 ± 0.84 542.3 ± 0.65 542.4 ± 1.04 545.3 ± 1.5a,b,c
Birth weight (gr) 7.7 ± 0.26 7.3 ± 0.2a 6.6 ± 0.2a,b 5.4 ± 0.3a,b,c
Total weight gain (gr) 181.4 ± 4.4 171.46 ± 3.5a 167.1 ± 3.1a 156.9 ± 1.5a,b,c
Gender (male %) 54 45 46 47
a
𝑃 < 0.05 compared to control group.
b
𝑃 < 0.05 compared to 2mg/kg/day group.
c
𝑃 < 0.05 compared to 4mg/kg/day group.
pregnancy and its effects on inflammatory serologic markers
such as nitrite oxide, TGF-𝛽, TNF-𝛼, IL-6, and CRP among
newborns, the present study was carried out to investigate
this phenomenon experimentally in rats. The present study
was launched to detect the inflammatory effects of nicotine
on rat embryo by exposing their mothers to different dosages
of nicotine during pregnancy.
2. Materials and Methods
2.1. Animals. By an experimental study, 32 healthy Wistar
rats (weights 150–180 gr), prepared by Pastor Institution in
Iran and kept at the same conditions including environmental
dampness (38% ± 2), light (12 hours darkness and 12 hours
lightness intermittently), temperature (22 ± 2∘), and free
access to food and water, were investigated. Each 2 virgin
female rats were located in a cage with one male rat for 24
hours and in the nextmorning vaginal smears were examined
andif sperm was found in the vaginal smear and vaginal
plugs existed, it was considered that they had mated [19].
After mating, the male rat was removed and each female was
placed in an individual cage until the end of study. All such
pregnant rats were categorised into 4 groups randomly. This
research was conducted in accordance with the Principles of
Laboratory Animal Care (NIH publication, revised in 1985)
and was approved prospectively by Ethics Committee of Ilam
University of Medical Sciences, Iran.
2.2. Nicotine Exposure. Totally 32 pregnant rats were divided
into 4 equal groups including the following: a control group
(receiving NaCl 9%, 10mg/kg/day) and 3 exposure groups
of nicotine tartrate (receiving 2mg/kg/day, 4mg/kg/day and
6mg/kg/day of solution (containing (-) nicotine, 56.1mg/mL
bacteriostatic saline, Sigma Co.). Rats were anesthetized by
inhalation of 1–3% isoflurane in oxygen and prepared with
Alzet osmoticminipumps (Model 2ML4,Du-rect, Cupertino,
CA) placed subcutaneously (back of the animal parallel to
the spine). Nicotine was infused via osmotic minipumps,
starting at the first day of pregnancy until parturition. Pumps
were filled with either NaCl 0.9% (sterile saline) or nicotine
salt solution. The concentration of the nicotine salt solution
was adjusted according to animal’s body weight, resulting
in a delivery of 2, 4, and 6mg/kg/day, levels approximately
equivalent to those that occur in mild and moderate to
heavy smokers [2]. Also injected dosages of nicotine and
physiological saline (NaCl 9%), in 4 groups, were calculated
in keeping with the weight of the pregnant rats every day.
2.3. Investigation of Serum Markers. A blood sample from
each rat’s newbornwas taken from inferior vena cava andwas
centrifuged at 4000×g for 15 minutes in +4∘C (temperature
rate during centrifuge) and its separated serum was then
kept at −70∘C (temperature rate until the end of study).
Serum hs-CRP, IL-6, TNF-𝛼, nitrite oxide, and TGF-𝛽 were
measured using Cusabio Biotech (0.04 ng/mL sensitivity),
Diaclone (19 pg/mL sensitivity), Diaclone (20 pg/mL sensi-
tivity), Cusabio Biotech (19.5 pg/mL sensitivity), ABACAM
(8 pg/mL sensitivity), and Abacam (19 pg/mL sensitivity)
company devices, respectively.
3. Statistical Analysis
Data were expressed as mean ± SD. The mean serum levels
of hs-CRP, IL-6, TNF-𝛼, TGF-𝛽, and NO were compared
between groups using Kruskal-Wallis or one-way ANOVA,
accordingly. All the pairwise multiple comparisons and the
comparisons between control and other groups were done
using Dunn’s nonparametric multiple comparison test.
4. Results
The general characteristics of rats, pregnancy, and newborn
rats are demonstrated in Table 1. The results showed that as
the dosages of nicotine were increased, the weight gains by
pregnant rats and the mean weight of their newborns were
significantly reduced.
Mean and SD of various serum markers among rats
pinkies exposed to the different dosages of nicotine are
demonstrated in Figures 1–5. Each exposure group was
compared to control group and to other exposure groups and
their relevant 𝑃 values are indicated as figure legends.
According to the results of this study mean ± SD of
hs-CRP was significantly higher among groups exposed to
various dosages of nicotine (2mg/kg (316.04 ± 50.2 ng/mL),
4mg/kg (427.3 ± 49.8 ng/mL), and 6mg/kg (527.3 ± 35.3
ng/mL)) compared to the control group (262.5 ± 17.5 ng/mL)
(𝑃 < 0.05, 𝑃 < 0.001, 𝑃 < 0.001, resp.) and its increasing rate
was also dose dependent (Figure 1).The results of comparison
between different exposure groups for hs-CRP are shown as
figure legends.
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Figure 1: Prenatal exposure to nicotine in pregnant rats increased
the inflammatorymarker hs-CRP in newborn rats.Mean± SDof the
hs-CRP marker is shown in different groups of newborns.𝑁 = 8 (a:
𝑃 < 0.05 in 2mg/kg group versus control group; b and c: 𝑃 < 0.001
in 4mg/kg group versus control group and 2mg/kg group, resp.; d,
e, and f: 𝑃 < 0.0001, 𝑃 < 0.0001, and 𝑃 < 0.001 in 6mg/kg group
versus control, 2mg/kg, and 4mg/kg groups, resp.).
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Figure 2: Prenatal exposure to nicotine in pregnant rats increased
inflammatory marker of IL-6 in newborn rats. Mean ± SD of the IL-
6 marker is shown in different groups of newborn rats. 𝑁 = 8 (a:
𝑃 > 0.05 in 2mg/kg group versus control group; b and c: 𝑃 < 0.001
and 𝑃 > 0.05 in 4mg/kg group versus control group and 2mg/kg
group, resp.; d, e, and f: 𝑃 < 0.0001, 𝑃 < 0.001, and 𝑃 < 0.001 in
6mg/kg group compared to control, 2mg/kg, and 4mg/kg groups,
resp.).
Mean ± SD of IL-6 among different exposed groups
to nicotine including 2mg/kg (39.4 ± 5.4 pg/mL), 4mg/kg
(43.2 ± 3.7 pg/mL), and 6mg/kg (52.5 ± 4.3 pg/mL) increased
compared to the control group (34.4 ± 7.5 pg/mL) (𝑃 = 0.07,
𝑃 < 0.001, and 𝑃 < 0.001, resp.) and showed a dose
dependent trend; however, the difference between group
exposed to 2mg/kg nicotine compared to the control group
was not significant (𝑃 = 0.07). 𝑃 values for difference
between groups exposed to 4 and 6mg/kg nicotine compared
to the control group were significant and its increasing rate
was dose dependent (Figure 2). The results of comparison
between different exposure groups for IL-6 are shown as fig-
ure legends.
Mean ± SD of TNF-𝛼 was considerably increased among
groups exposed to the dosages of 4mg/kg (414.3 ± 34.7
pg/mL) and 6mg/kg nicotine (485.8± 44.5 pg/mL) compared
to the control group (263.3 ± 32.6 pg/mL) with significant
differences (𝑃 < 0.05,𝑃 < 0.001, resp.); however, comparison
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Figure 3: Prenatal exposure to nicotine in pregnant rats increased
the inflammatory marker TNF-𝛼 in newborn rats. Figure shows
mean ± SD of the TNF-𝛼 marker in different groups of newborn
rats. 𝑁 = 8 (a: 𝑃 > 0.05 in 2mg/kg group versus control group;
b and c: 𝑃 < 0.001 and 𝑃 > 0.05 in 4mg/kg group versus control
group and 2mg/kg group, resp.; d, e, and f: 𝑃 < 0.0001, 𝑃 < 0.0001,
and 𝑃 < 0.05 in 6mg/kg group compared to control, 2mg/kg, and
4mg/kg groups, resp.).
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Figure 4: Prenatal exposure to nicotine in pregnant rat increased
inflammatory marker TGF-𝛽 in newborn rats. Mean ± SD of the
TGF-𝛽marker is shown in different groups of newborn rats.𝑁 = 8
(a:𝑃 > 0.05 in 2mg/kg group versus control group; b and c:𝑃 < 0.05
and 𝑃 > 0.05 in 4mg/kg group versus control group and 2mg/kg
group, resp.; d, e, and f: 𝑃 < 0.0001, 𝑃 < 0.0001, and 𝑃 < 0.001 in
6mg/kg group compared to control, 2mg/kg, and 4mg/kg groups,
resp.).
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Figure 5: Prenatal exposure to nicotine in pregnant rat increased
inflammatory marker nitrite oxide in newborn rats. Mean ± SD of
the NO marker in different groups of newborn rats. 𝑁 = 8 (a: 𝑃 >
0.05 in 2mg/kg group versus control group; b and c: 𝑃 < 0.05 and
𝑃 > 0.05 in 4mg/kg group versus control group and 2mg/kg group,
resp.; d, e, and f: 𝑃 < 0.001, 𝑃 < 0.001, and 𝑃 < 0.05 in 6mg/kg
group compared to control, 2mg/kg, and 4mg/kg groups, resp.).
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between the group exposed to 2mg/kg nicotine (317.4 ±
40.6 pg/mL) and the control group did not show a significant
difference (Figure 3). The results of comparison between
different exposure groups for TNF-𝛼 are shown as figure
legends.
Mean ± SD of TGF-𝛽 among the group exposed to
2mg/kg of nicotine (6.25 ± 0.89 ng/mL) compared to the
control group (6.1 ± 0.7 pg/mL) did not show a significant
difference; however, there was a significant difference in
nicotine exposure groups of 4mg/kg (7.5 ± 1.4 ng/mL) and
6mg/kg (9.9 ± 1.4 ng/mL) compared to the control group
(𝑃 < 0.05, 𝑃 < 0.001, resp.) (Figure 4). The results of
comparison between different exposure groups for TGF-𝛽 are
shown as figure legends.
Though increasing the dosages of nicotine showed a mild
increase in themean± SD serum levels of nitrite oxide among
nicotine exposure groups of 2mg/kg (54.7 ± 1.3 𝜇mol/L)
and 4mg/kg (57.4 ± 5.7 𝜇mol/L), only the group exposed to
6mg/kg of nicotine (64.8 ± 3.8 𝜇mol/L) showed a significant
difference (𝑃 < 0.001) in comparison with the control group
(51.3 ± 1.99 𝜇mol/L) (Figure 5). The results of comparison
between different exposure groups for nitrite oxide are shown
as figure legends.
5. Discussion
The present study was launched to detect the inflammatory
effects of nicotine on rat embryo by exposing theirmothers to
different dosages of nicotine during pregnancy. Investigated
serum markers were TGF-𝛽, TNF-𝛼, IL-6, hs-CRP, and
nitrite oxide. All these markers were affected by nicotine
significantly. The results of this study also showed a dose
dependent trend for almost all the studied serum markers
among the exposed groups. For instance, increasing the
dosages of nicotine during pregnancy significantly increased
the above mentioned serum markers. Many diseases are
associated with disturbances of these serum markers and
their disturbances are also the precursors of some autoim-
mune and organic diseases. Vascular diseases are usually
accompanied with disturbances of inflammatory markers
such as Leptin, IL-6, CRP, TNF-𝛼, and E-selectin [18, 20–
22]. Leptin, IL-6, and CRP via deduction of nitrite oxide
affect the endothelial activities and this process causes vas-
cular contraction, leucocytic adherence, platelets activation,
oxidative stress, and thrombosis that will result in endothelial
dysfunction. These disturbances will be accompanied later
with atherosclerosis [23–25]. Some studies reported that
smoking during pregnancy causes variations in the activities
of immunologic systems of newborns and it also causes a
restraint of the anti-inflammatory markers such as IL-10 and
a rise in the preinflammatory markers such as TNF-𝛼, IL-6,
IL-1b, IL-8, and GM-CSF [26]. According to a study by Gaun
and others nicotine can change the perivascular fat and affect
the vascular contractions causing hypertension [15]. There
are different studies to report the mechanism and pathologic
effects of nicotine on cardiac development and its activities
during pregnancy. A study by Negi and colleagues by an
experimental study reported that prenatal application of
nicotine causes arterial hypertension of embryo, reduction of
oxygen saturation of the blood, and reduction of palpitation
in the embryo [17]. Another study by Baykan and coworkers
reported that exposing pregnant rats to nicotine caused a
reduction of the antioxidant enzymes of myocardium and a
rise in the production of peroxides lipids and free radicals
of their newborns [16]. Also exposing pregnant rats to
nicotine caused an increase in the secretion of sympathetic
neurotransmitters of their newborns and, by suppressing the
PKC gene, caused rising of cardiac complications in their
embryo [4]. Some other studies have reported the effects of
prenatal exposure of rats to nicotine and its associated effects
on cardiovascular system such as tachycardia, arrhythmia,
ischemia, and atherosclerosis [27–30]. Totally, all nicotine
exposed groups showed disturbances of the serum levels of
all the evaluated inflammatory markers in comparison with
the nonexposed group and a dose dependent trend was seen
among almost all the evaluated markers in exposed rats. In
accordance with the results of our study, almost all reports in
this field have confirmed that maternal smoking or prenatal
nicotine application shows deleterious effects or serologic
disturbances on their embryo.
6. Conclusion
The current study showed that exposing pregnant rats to
nicotine causes a dose dependent increasing trend for all the
studied inflammatory serummarkers among their newborns.
This phenomenon can result in some complications and
diseases associated with these serologic disturbances.
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